Karen A. Foster is Chief Quality and Operations of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 157,568 shares of BLFS, which is worth approximately $3.69 Million. The most recent transaction as insider was on Sep 16, 2024, when has been sold 267 shares (Common Stock) at a price of $25.12 per share, resulting in proceeds of $6,707. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 158K
0.23% 3M change
25.7% 12M change
Total Value Held $3.69 Million

Karen A. Foster Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2024
SELL
Open market or private sale
$6,707 $25.12 p/Share
267 Reduced 0.17%
157,568 Common Stock
Aug 21 2024
SELL
Open market or private sale
$2,458 $25.61 p/Share
96 Reduced 0.06%
157,835 Common Stock
Jul 18 2024
SELL
Open market or private sale
$5,400 $22.5 p/Share
240 Reduced 0.15%
157,931 Common Stock
May 29 2024
SELL
Open market or private sale
$8,886 $21.78 p/Share
408 Reduced 0.26%
158,171 Common Stock
May 17 2024
SELL
Open market or private sale
$1,885 $22.18 p/Share
85 Reduced 0.05%
158,579 Common Stock
Apr 18 2024
SELL
Open market or private sale
$7,364 $15.31 p/Share
481 Reduced 0.3%
158,664 Common Stock
Mar 27 2024
SELL
Open market or private sale
$7,106 $17.99 p/Share
395 Reduced 0.25%
159,145 Common Stock
Mar 12 2024
SELL
Open market or private sale
$85,938 $16.6 p/Share
5,177 Reduced 3.14%
159,540 Common Stock
Mar 11 2024
SELL
Open market or private sale
$5,556 $17.42 p/Share
319 Reduced 0.19%
164,717 Common Stock
Mar 08 2024
BUY
Grant, award, or other acquisition
-
41,096 Added 19.94%
165,036 Common Stock
Feb 21 2024
SELL
Open market or private sale
$1,509 $17.35 p/Share
87 Reduced 0.07%
123,940 Common Stock
Jan 19 2024
SELL
Open market or private sale
$20,078 $16.76 p/Share
1,198 Reduced 0.96%
124,027 Common Stock
Jan 02 2024
SELL
Open market or private sale
$10,066 $16.75 p/Share
601 Reduced 0.48%
125,225 Common Stock
Dec 17 2023
BUY
Grant, award, or other acquisition
-
228 Added 0.18%
125,568 Common Stock
Dec 03 2023
BUY
Grant, award, or other acquisition
-
258 Added 0.2%
125,826 Common Stock
Dec 01 2023
SELL
Open market or private sale
$5,764 $12.37 p/Share
466 Reduced 0.37%
125,340 Common Stock
Nov 19 2023
BUY
Grant, award, or other acquisition
-
267 Added 0.21%
125,806 Common Stock
Nov 13 2023
SELL
Open market or private sale
$1,227 $10.77 p/Share
114 Reduced 0.09%
125,539 Common Stock
Nov 05 2023
BUY
Grant, award, or other acquisition
-
299 Added 0.24%
125,653 Common Stock
Oct 22 2023
BUY
Grant, award, or other acquisition
-
335 Added 0.27%
125,354 Common Stock
Oct 08 2023
BUY
Grant, award, or other acquisition
-
252 Added 0.2%
125,019 Common Stock
Sep 28 2023
SELL
Open market or private sale
$8,042 $14.16 p/Share
568 Reduced 0.45%
124,767 Common Stock
Sep 24 2023
BUY
Grant, award, or other acquisition
-
260 Added 0.21%
125,335 Common Stock
Sep 10 2023
BUY
Grant, award, or other acquisition
-
330 Added 0.26%
125,075 Common Stock
Aug 27 2023
BUY
Grant, award, or other acquisition
-
403 Added 0.32%
124,745 Common Stock
KAF

Karen A. Foster

Chief Quality and Operations
Bothell, WA

Track Institutional and Insider Activities on BLFS

Follow BIOLIFE SOLUTIONS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS